Ionis Pharmaceuticals, Inc.
IONS
$32.96
$0.060.18%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -104.35M | -140.48M | -66.27M | -142.80M | -9.26M |
| Total Depreciation and Amortization | 5.27M | 5.49M | 5.58M | 5.65M | 5.61M |
| Total Amortization of Deferred Charges | 1.67M | 1.68M | 1.67M | 1.67M | 1.66M |
| Total Other Non-Cash Items | 42.65M | 26.78M | 33.16M | 31.07M | 21.87M |
| Change in Net Operating Assets | -61.39M | -8.46M | -94.03M | -45.52M | 12.99M |
| Cash from Operations | -116.14M | -114.99M | -119.88M | -149.94M | 32.87M |
| Capital Expenditure | -25.50M | -9.06M | -6.23M | -4.49M | 819.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.71M | -331.74M | 68.68M | 80.60M | -27.53M |
| Cash from Investing | 68.21M | -340.80M | 62.45M | 76.11M | -26.71M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -44.55M | -48.00K | -39.00K | -39.00K | -38.00K |
| Issuance of Common Stock | 429.00K | 496.10M | 2.60M | 23.61M | 40.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -44.12M | 496.05M | 2.56M | 23.57M | 40.72M |
| Foreign Exchange rate Adjustments | -486.00K | 350.00K | -23.00K | -114.00K | 330.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.53M | 40.61M | -54.90M | -50.38M | 47.21M |
